The Wnt signaling pathway is activated by mutations in the adenomatous polyposis coli (APC) or b-catenin genes in most colon cancers, leading to the transactivation of promoters containing binding sites for the Tcf/LEF family of transcription factors. We have previously shown that it is possible to confer colon cancer specificity on autonomous parvoviruses by inserting Tcf sites into the viral P4 promoter. The mutant Tcf promoters were responsive to activation of the Wnt pathway but the viruses replicated poorly. We show here that reduction of the number of Tcf sites from four to two leads to an increase in the efficiency of replication and toxicity of the viruses in Co115 colon cancer cells, with only a small reduction in selectivity for cells with an active Wnt signaling pathway. Despite this improvement, virus production by most colon cancer cells remained low. Analysis of parental phH1 virus infection of SW480 colon cancer cells showed that the nonstructural and capsid proteins were expressed, but single stranded DNA and progeny virus were not produced. This defect reflects the dependence of autonomous parvoviruses on host functions for many steps in their replication cycle and represents a major limitation to the use of selectively replicating parvoviruses for colon cancer therapy.
Introduction
Autonomous parvoviruses are among the smallest DNA viruses. Unlike adeno-associated virus (AAV), they are able to replicate without the aid of a helper virus. They have a 5 kb genome containing two transcription units, which are regulated by the P4 and the P38 promoters (reviewed by Berns 1 ). The P4 promoter drives the expression of the nonstructural proteins NS1 and NS2, and the P38 promoter drives the expression of the structural proteins VP1 and VP2. Owing to their low genetic complexity, parvoviruses are highly dependent on cellular functions for their replication. 2 They are sensitive to the growth state of the cells they infect, and in general will replicate only in cells that are actively dividing. Rodent parvoviruses, such as MVM or H1, replicate preferentially in, and consequently kill, transformed cells. Furthermore, the formation of spontaneous, virally or chemically induced tumors is reduced in parvovirus-infected animals. [3] [4] [5] [6] These oncolytic properties make rodent parvoviruses interesting vectors for cancer therapy. 7 Virtually all colon cancer cells possess an active Wnt signaling pathway, which results in the stabilization of b-catenin and transactivation of promoters containing binding sites for the Tcf/LEF family of transcription factors (reviewed by Polakis 8 ). In order to restrict parvovirus replication to colon cancer cells, we previously inserted four Tcf-binding sites into the P4 promoter of phH1, an MVM-H1 hybrid virus. 9 We showed that NS1 expression, viral replication and cytotoxicity were restricted to cells with high Tcf activity. 10 However, we found that these viruses had two main limitations. The first was that the Tcf-P4 promoter had unacceptably low activity in some colon cancer cells, particularly those with low Tcf activity like Co115. The second was that the viral burst size was low in most of the colon cancer cells tested. We show here that the activity of the promoter can be improved in many colon cancer cells by reducing the number of Tcf sites from four to two. The resulting viruses are able to replicate in the Co115 colon cancer cell line but not in the majority of colon cancer cell lines tested. We show that this is due to a block in the viral replication cycle after expression of the nonstructural and capsid proteins, which is unrelated to the Tcf site insertion.
Materials and methods

Cell lines
HT29 and 293T cells were supplied by ATCC. Isreco1 and SW480 cells were provided by Dr B Sordat. HeLa cells were supplied by the Dr D Lane. NB324K cells were supplied by Dr P Beard. CR2 cells were derived from 293T cells by infection with a lentivirus expressing myc-tagged DN-b-catenin.
11 LS174T L8 cells were supplied by Dr M van de Wetering. DN-Tcf4 expression was induced by adding 1 mg/ml of doxycycline to the medium. All cells except the LS174T L8 were grown in DMEM with 10% FCS. The LS174T L8 cells were grown in RPMI with 5% FCS.
Parvovirus mutagenesis
The Tcf parvoviruses with four Tcf sites in the P4 promoter were described by Malerba et al. 10 To construct the vectors with two Tcf sites, plasmids pMM42, 44, 46, 48 10 were cut with BamHI/BglII and self-ligated, to give pMM99-103. The 2820 bp SpeI-SspI fragment of pMM99-103 was inserted into the same sites in phH1, 9 to give pMM104-108, the plasmids used to make viruses vMM104-108.
Parvovirus amplification
Virus was produced by cotransfection of the phH1-derived plasmids and pXNS1
12 into cR2 cells. At 3 days posttransfection, cells were harvested by scraping, washed once in PBS and resuspended in 50 mM Tris, 0.5 mM EDTA pH 8.7. Virus was released by five rounds of freeze/thawing, cell debris was pelleted by centrifugation and the viruscontaining supernatant was stored at 41C.
Virus titration by HT29 PCR assay
For experiments with Tcf-regulated viruses, viral titers were estimated by measuring the amount of viral DNA in HT29 colon cancer cells 24 h after infection in the presence of hydroxyurea. This approach was used to avoid underestimating the titer by plaque assay or infectious center assay on nonpermissive indicator cells such as NB324K. None of the viruses replicates in HT29 cells in the presence of hydroxyurea. The amount of viral DNA was measured by quantitative PCR as described by Malerba et al. 10 and expressed as the number of genome copies/ml.
Virus titration by NB324K plaque assay NB324K cells (3.5 Â 10 5 ) were seeded in 6-cm dishes the day before infection. Cells were infected in triplicate with serial 10-fold dilutions of the cell lysate in serum-free DMEM. At 1 h postinfection, the medium was replaced by a medium containing 0.9% Bactoagar (Invitrogen). At 6 days postinfection, the agar layer was removed, cells were fixed with 4% formaldehyde in PBS and stained with 1% crystal violet in 20% methanol. Plaques were counted and the titer was expressed as plaque-forming units (PFU) per millilitre of virus suspension.
Western blotting
Cells were infected at a multiplicity of 500 viral genome copies/cell for 1 h in serum-free DMEM, after which the medium was replaced with DMEM containing 10% FCS. Cells were harvested 24 h later. NS1 expression was detected with SP8 rabbit polyclonal antibody provided by Dr N Salome´. VP expression was detected with the anti-VP (H1 virus) antibody provided by Dr C Dinsart. The myc-tagged DN-b-catenin was detected with anti-bcatenin antibody C19220 (Transduction Laboratories). The Tcf4 and DN-Tcf4 proteins were detected with the anti-Tcf4 antibody N-20 (Santa Cruz).
MTT assay
Cells in 96-well plates were infected in triplicate with 1000 viral genome copies/cell for 1 h in serum-free DMEM, after which the medium was replaced with DMEM containing 10% FCS. At day 0-4 postinfection, 10 ml of 5 mg/ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheny-2H tetrazolium bromide (thiazolyl blue, MTT, Sigma) were added to each well and incubated at 371C for 4 h. The medium was removed, and the wells were dried at 371C for 30 min. Isopropanol (100 ml) was added to each well and mixed by shaking the plates for 30 min. The absorbance at 570 nm was read and the values for the infected wells were normalized to the mock-infected wells. Statistical significance was tested by two-tailed t-test assuming equal variance.
Results
Decreasing the number of Tcf sites in the P4 promoter increases promoter activity We and others have previously noted that the level of Tcf activity measured with luciferase or viral reporters is quite variable in colon cancer cells lines. 13, 14 The level of expression of NS1 from the Tcf-regulated parvoviruses described by Malerba et al. 10 was broadly consistent with other measures of Tcf activity in these cells, but some cell lines gave lower than expected NS1 expression. A possible explanation for this is that the insertion of four Tcf sites in the P4 promoter may interfere with left hairpin function, leading to a reduction in viral DNA replication and a decrease in the amount of template DNA available for transcription. To produce a promoter closer in size to the parental MVM P4 promoter, we deleted two of the Tcf sites. As before, the promoters retain most of the normal sequence, with replacement of specific native transcription factor binding sites by the Tcf sites in vMM105, 106 and 107 ('2Tcf viruses', Figure 1 ).
To test the ability of the 2Tcf promoters to respond to Wnt signals, LS174T L8 cells 15 were infected with the 2Tcf viruses in the presence or absence of doxycycline. The Wnt pathway is constitutively active in the parental LS174T colon cancer cell line because of a mutation in b-catenin. The L8 derivatives express a dominant-negative Tcf4 protein from a 'tet-on' promoter. This assay tests only P4 promoter function, because of a defect in viral replication in these cells (data not shown). In the absence of doxycycline, all of the 2Tcf viruses expressed NS1 at wild-type levels. Repression of Tcf-dependent transcription following doxycycline addition had no effect on NS1 expression by phH1, but inhibited NS1 expression by all of the mutant viruses ( Figure 2a ).
To show that the 2Tcf viruses can respond to activation of the Wnt signaling pathway in cells permissive for MVM and H1 virus replication, 293T cells and derivatives expressing an oncogenic mutant of b-catenin (cR2 cells) were infected with phH1 or the 2Tcf viruses. Western blotting showed that NS1 expression was detectable in parental 293T cells infected with wild-type phH1 virus but not the 2Tcf mutants ( Figure 2b , upper panels). In contrast, NS1 was detectable with phH1 and all of the mutants except vMM107 in cR2 cells, where the Wnt signaling pathway has been activated by expression of DN-b-catenin ( Figure 2b , lower panels). The Tcf sites in vMM107 replace the Sp1 binding site, which is essential for normal P4 promoter function in many cells, 16 so poor NS1 expression by this virus is expected. Virus replication was measured indirectly by plating lysates of infected cells on an indicator cell line (HT29) in the presence of hydroxyurea and quantifying the amount of viral DNA. This approach was taken because the Wnt pathway is not active in the cell lines normally used to titer H1. Measured in this way, replication of the 2Tcf viruses in 293T was 100-1000-fold attenuated compared to phH1 (data not shown). Activation of Wnt signaling by the b-catenin mutant led to a 10-100-fold increase in production of all of the 2Tcf viruses (Figure 2c ). Wnt pathway activation thus increased virus replication, but not to wild-type levels, consistent with the stronger NS1 expression by phH1 than the Tcf viruses in cR2 cells in Figure 2b .
As a further test of the selectivity of the 2Tcf viruses, HeLa and NB324K cells were examined. These cell lines are known to be permissive for H1 replication and have an inactive Wnt pathway. NS1 expression was undetectable following infection with the 2Tcf viruses (Figure 3a) , and virus production was reduced 10-100-fold compared to the parental phH1 virus (Figure 3b ). Taken together, these results show that the 2Tcf promoters are responsive to the level of activation of the Wnt signaling pathway and viral replication is impaired in the absence of Wnt signaling.
NS1 expression and virus replication in colon cancer cells
To determine whether the 2Tcf viruses express NS1 efficiently in colon cancer cells, we tested a panel of cell lines known to have different levels of Tcf activity. SW480 have high Tcf activity, Co115 and Isreco1 have intermediate Tcf activity, and Hct116 and HT29 have low Tcf activity. 13 In all of the cell lines, the best NS1 expression was seen with vMM104 and 108 (Figure 4a ). The transcription factor binding sites in the core promoter (E2F, ets and Sp1) are retained in these viruses. Among the viruses with replacement of these sites, the most active was vMM106, in which the ets site is deleted. Consistent with previous reports, deletion of the Sp1 site strongly reduced NS1 expression (vMM107, Figure 4a ). In general, the level of NS1 expression followed the pattern of Tcf activity in the different cell lines. Only in SW480 was the level of NS1 expression higher with the 2Tcf viruses than with phH1 ( Figure 4a ). This is consistent with the known high level of Tcf activity in SW480.
Virus production measured by HT29 PCR assay is shown in Figure 4b . In SW480 and Isrec01, the virus yield was higher with the Tcf viruses than phH1. There was a fairly good correlation between NS1 expression and virus yield, except in Isrec01. To explain the discrepancy, NS1 expression in Isrec01 was retested by Western blotting at 48 h, the time at which virus was harvested for the burst assay. NS1 expression in Isrec01 at 48 h showed a better correlation with virus production, although vMM105 still gave less NS1 expression than expected for the level of replication (compare Figure 4a  and b) . We conclude that, in general, cell lines with higher Tcf activity show higher NS1 expression and viral replication, but there is some unexplained variation related to the site in the promoter where the Tcf sites are inserted. Figure 1 Schematic representation of the MVM P4 promoter. Mutant numbers 19 and 22-25 refer to the original P4 linker scanning mutants described by Deleu et al. 16 The genomic sequence of the wild-type and 2Tcf mutant promoters is shown (note that the sequence orientation is 3 0 to 5 0 ).
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Restriction of parvovirus replication in colon cancer cells
The burst data are presented relative to phH1 in Figure 4 to permit analysis of the effect of the Tcf sites. The absolute burst size of phH1 was 0.04 in SW480, 0.08 in Isreco1, 4 in Co115, 0.3 in Hct116 and 0.3 in HT29. In absolute terms, only Co115 has a burst size comparable to that in highly permissive cell lines like NB324K. The ability of Co115 to replicate the virus explains the uniform NS1 expression by all of the Tcf viruses: the NS1 level in these cells is probably determined by the high template copy number ( Figure 4a , the exception is vMM107, which fails to amplify the template because of weak promoter activity). Since poor virus replication emerges as a major limitation to Tcf virus activity despite good promoter regulation, we analyzed NS1 and capsid protein expression by wild-type phH1 virus to identify the step in the viral cycle where the block occurs. In NB324K, NS1 and VP expression increased up to 48 h postinfection, then decreased (Figure 5a , middle panels). The late decline in expression is probably caused by cell death accompanying lytic infection. In Co115 and SW480, NS1 and VP protein expression increased progressively over the 96 h following infection. These data rule out a major restriction in the viral life cycle prior to DNA replication, because Targeting of autonomous parvoviruses M Malerba et al decapsidation and completion of the second strand are required for expression of the viral proteins, and they rule out a problem with P38 activation because the capsid proteins were expressed even at the earliest time point. Viral burst size was measured in the three cell lines, with estimation of the titer by NB324K plaque assay (this was possible in this case because only the wild-type phH1 virus was tested). Despite expressing viral proteins, the amount of virus that could be recovered from the cells decreased with time in the SW480 cultures (Figure 5b ). This is in marked contrast to what was seen with NB324K and Co115. After an eclipse phase, both cell lines produced a burst of virus at 24 h, with a further smaller increase in NB324K at 48 h (Figure 5b ). We conclude that there is a block to virus replication in SW480 cells after the step of viral protein expression. 
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Comparison of 2Tcf and 4Tcf viruses in toxicity assays Co115 emerge from the above studies as the only colon cancer cell line we have tested in which the Tcf-regulated parvoviruses replicate well. To determine how important replication is for tumor cell killing, we performed MTT assays on Co115 cells, NB324K cells and SW480 cells. vMM106 was selected for this comparison because it showed the best combination of selectivity and activity, and it was compared with the equivalent 4Tcf virus (vMM70) to demonstrate the superiority of the 2Tcf configuration. At the level of NS1 expression, vMM106 was clearly better than vMM70 (Figure 6a) . The results of the MTT assays are shown in Figure 6b -d. phH1 efficiently killed NB324K, whereas the Tcf viruses were much less effective in this cell line, which lacks Wnt pathway activation (Figure 6b) . Despite the low level of replication seen in SW480, all of the viruses showed some activity, suggesting that viral protein expression can be toxic even without viral replication (Figure 6c ). Consistent with the poor NS1 expression with vMM70 (Figure 6a ), phH1 and vMM106 were both more toxic than vMM70 in Co115 (Figure 6d) . The difference in toxicity of vMM70 vs vMM106 in Co115 was statistically significant (P ¼ 0.004, 0.026 and 0.001 on days 2, 3 and 4, respectively). We conclude that the 2Tcf viruses are more toxic than the 4Tcf viruses, and that viral replication is not essential for cell killing.
Discussion
We have shown here that reducing the number of Tcf-binding sites in our viruses increases the activity of the P4 promoter in cells with active Wnt signaling. Although most colon cancer cells possess an active Wnt pathway, their ability to transactivate a Tcf reporter is quite variable. This has been attributed to export of b-catenin from the nucleus by the adenomatous polyposis coli protein (APC). 13 In cells with b-catenin mutations, like Hct116, APC is wild type and can efficiently export b-catenin from the nucleus. These cells thus tend to have low Tcf activity. In cells with APC mutations, like SW480, the level of Tcf activity is generally higher because most of the mutations found in tumors delete the central nuclear export signals (NES) in APC. A minority of APC mutant cells, like HT29, have low Tcf activity because the APC mutation occurs after the central NES. The differences in NS1 expression from the 2Tcf viruses in the different cell lines broadly reflect the variation in Tcf activity. Compared with the 4Tcf viruses, P4 activity was higher with the 2Tcf viruses. This could reflect a precise spacing requirement for the promoter, but we previously showed that the 4Tcf promoters had wild-type activity in luciferase assays using transfection of plasmid DNA. The extreme sensitivity of the promoter in the context of the virus suggests that factors related to the functioning of the viral hairpin may be more important in vivo, for example at the level of correct recruitment of NS1 and subsequent viral DNA replication. To distinguish between these models it would be possible to mutate rather than delete the two superfluous Tcf sites in the 4Tcf viruses. Targeting autonomous parvovirus replication to specific cell types by modifying the P4 promoter has also been successfully performed by inserting transcription elements Targeting of autonomous parvoviruses M Malerba et al from the HIV-1 LTR or a tet operator, which conferred selectivity for cells expressing HIV-1 tat and a synthetic transcriptional repressor (tet-KRAB), respectively. 17, 18 Taken together, these studies and the results presented here provide strong support for the concept that autonomous parvoviruses can be targeted to tumors by modifying the parvoviral P4 promoter, provided the right tumor/virus combination can be found. Despite the increased activity of the 2Tcf promoters, most colon cancer cells were not permissive for parvovirus replication. This permissivity problem is a major obstacle to the development of replicating parvoviruses for colon cancer therapy. Our data suggest that the block in parvovirus replication in SW480 occurs after second strand synthesis and viral protein expression, but a complete description of the restrictions to parvovirus replication in human colon cancer cell lines is beyond the scope of this report. Cells containing a functional p53 are resistant to H1 parvovirus toxicity. 19 Since SW480 cells have a R273H mutation in p53, 20 the resistance of SW480 cells to phH1 is unlikely to be caused by p53. Analysis of the viral DNA produced during infection showed that small amounts of monomeric and dimeric replicative form DNA were present early but did not increase over time. Instead, a smear of smaller DNA molecules was produced (data not shown). This most likely reflects a deficiency of host factors that are essential for parvovirus replication. Many of the human cell lines known to be very permissive for H1, like NB324K and 293T, are transformed by SV40 large T antigen. Furthermore, unlike normal human fibroblasts, SV40-transformed fibroblasts are able to sustain a productive H1 production and are more susceptible to the cytocidal activity of the virus. 21 It seems unlikely that the permissivity is due to inactivation of p53 and Rb by T antigen, because HEK 293 cells, from which 293T are derived, express adenoviral E1A and E1B proteins that can inactivate p53 and Rb. Thus, other functions of T antigen may be important, for example the DNA binding, ATPase or helicase activities. To test the role of T antigen in colon cancer cells, we have engineered SW480 cells to express T antigen. Unfortunately, the T antigen-expressing derivatives were only slightly more sensitive to hH1 virus-induced killing than the parental cells (data not shown).
Despite the poor replication of the viruses in colon cancer cells, the toxicity assays showed that viral infection was toxic even in the least permissive cells, like SW480. Given, what is known about NS1 in other cell lines, this toxicity can reasonably be attributed to NS1, which was expressed in SW480 despite the lack of template amplification. Replication requires NS1, so it can not occur when the P4 promoter is repressed by Tcf in the absence of Wnt activation. The increase in template copy number following DNA replication is thus both a cause and a consequence of high NS1 expression. Tcf regulation of the P4 promoter provides a means to restrict parvovirus toxicity to cells with activation of Wnt signaling, but the primary reason for using a replicating virus in this context is to allow amplification of the virus within the tumor. The failure of this secondary amplification to occur in most colon cancer cell lines currently represents a major limitation to the use of a replicating H1 virus for colon cancer therapy. To overcome this problem, other serotypes or related viruses known to grow in human cells could be screened to find viruses that exhibit a greater tropism for colon cells than H1 virus. Alternatively, it should be possible to select virus variants adapted to grow in colon tumor cells by sequential passaging, and use these viruses as the starting material for further promoter modifications to enhance the selectivity. Once these viruses are available, additional mutations can be introduced in the nonstructural genes to sensitize host cells to virus-mediated cell killing and increase the therapeutic efficacy. 22 
